Figure 4From: Biological behaviors and proteomics analysis of hybrid cell line EAhy926 and its parent cell line A549Tumorigenicity of Eahy926 and A549 cells in vivo. (A) No tumor mass formed roughly within 14 days after s.c. injection of Eahy926 cells; (B) Tumor mass formed roughly within 10 days after s.c. injection of A549 cells; (C) On day 14 after s.c inoculation of Eahy926 cells; tissues collected from the inoculative site were identified as inflammatory necrosis in the Eahy926 cells group; (D) On day 14 after s.c inoculation of A549 cells, classic tumor microstructure was found in the A549 cells group and the rate of tumorigenicity was 100%.Back to article page